Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases

Cellenkos, Inc. Saudi Arabia Texas

KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host DiseaseCellenkos to Support Local Cell and Gene Therapy Manufacturing at KFSHRCView original content:https://www.prnewswire.co.uk/news-releases/cellenkos-inc-and-king-faisal-specialist-hospital--research-centre-sign-strategic-mou-to-advance-t-regulatory-cell-therapies-for-unmet-diseases-302463389.html